SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-003480
Filing Date
2021-02-01
Accepted
2021-02-01 06:30:21
Documents
14
Period of Report
2021-02-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qtnt-8k_20210201.htm   iXBRL 8-K 30106
2 EX-99.1 qtnt-ex991_25.htm EX-99.1 623452
3 GRAPHIC gcjh2i4vii5l000001.jpg GRAPHIC 17467
  Complete submission text file 0001564590-21-003480.txt   836375

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20210201.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20210201_lab.xml EX-101.LAB 20168
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20210201_pre.xml EX-101.PRE 12073
7 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-8k_20210201_htm.xml XML 3667
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 21574238
SIC: 2835 In Vitro & In Vivo Diagnostic Substances